A synergic collaboration between Informa Markets and Ipack Ima S.r.l. was announced in Milan (Italy) to become a single global reference point for processing and packaging companies.
Dr. Prinjha will be responsible for the therapeutic portfolio strategy to advance the Company’s growing pipeline of first-in-class assets, including a dual HIF-1/HIF-2 inhibitor and an inhibitor of ATIC homodimerisation.
James Bury, director technology at Tjoapack, examines the increasing need for innovative solutions in pharmaceutical packaging, emphasising novel approaches and emerging technologies that address changing packaging requirements.
The expansion includes increased production capacity at ACG Capsules’ Croatian facility and the opening of new warehousing and slitting facilities by ACG Packaging Materials division.
Exothera, a GMP-certified CDMO offering a complete range of services for viral vectors, RNA therapeutics, and vaccines, has announced the appointment of a new CEO, Cédric Volanti.
Stephan Von Schilcher, global strategic account manager at Systech, discusses the repercussions of counterfeit drug epidemic on patients and what pharma companies must to combat the problem.
Mestag Therapeutics announced that it has entered into a license and collaboration agreement with MSD to identify novel targets for the development of therapies against inflammatory diseases.
Thermo Fisher Scientific will showcase its latest innovations enabling the molecule-to-medicine journey and host a series of sessions that feature industry developments during CPHI Milan 2024.
Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announced the acquisition of Alderley Analytical Ltd, based near Manchester, UK.
SGS, a testing, inspection and certification company, announced it will be an exhibitor at the Convention on Pharmaceutical Ingredients (CPHI) Milan 2024.
